TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2005–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	2	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	5	1
2017	—	5	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	4	1
2007	—	2	1
2006	—	2	1
2005	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FIRST STRATEGIC	—	83

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	72
HOUSE OF REPRESENTATIVES	59

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	68
Defense	Defense	61
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	20
Health Issues	Health Issues	5
Science/Technology	Science/Technology	2

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 2022117th Congress

Ending the Diagnostic Odyssey Act of 2021

2021 · fourth_quarter · Firm: FIRST STRATEGIC

Cited source text and reported amounts

S.2022, Ending the Diagnostic Odyssey Act.

Client expense: — · Firm income: $20,000

Matched citations: S.2022

S. 2022117th Congress

Ending the Diagnostic Odyssey Act of 2021

2021 · third_quarter · Firm: FIRST STRATEGIC

Cited source text and reported amounts

S.2022, Ending the Diagnostic Odyssey Act.

Client expense: — · Firm income: $20,000

Matched citations: S.2022

S. 2022117th Congress

Ending the Diagnostic Odyssey Act of 2021

2021 · second_quarter · Firm: FIRST STRATEGIC

Cited source text and reported amounts

S.2022, Ending the Diagnostic Odyssey Act.

Client expense: — · Firm income: $20,000

Matched citations: S.2022

TRANSLATIONAL GENOMICS RESEARCH INSTITUTE — Lobbying Disclosure | Poliscope